S0704 Treatment Outcome of Tofacitinib Dose Reduction to 5 mg BID vs Remaining on 10 mg BID in Patients With UC Who Were in Stable Remission on 10 mg BID: 6-Month Data From the Double-Blind, Randomized RIVETING Study